Answers are grounded in this paper and cite their sources.
As health care systems worldwide seek to decentralize diagnostics and expand precision medicine, silicon photonic biosensors have become a compelling solution. Their development over the past decade, especially in the last 5 years, marks a significant convergence of photonics, nanotechnology, and biomedical engineering that aims to reshape the diagnostic landscape. This review presents a comprehensive analysis of advances in silicon photonic biosensors, focusing on key configurations including microring resonators, photonic crystals, interferometers, and other emerging transduction mechanisms. We discuss the integration of advanced surface functionalization strategies for efficient and robust bioreceptor immobilization, which is critical for reliable biomedical applications. We emphasize the translation of these devices into clinical settings, primarily in infectious diseases and cancer diagnostics. Finally, we address current limitations, such as fabrication complexity, microfluidic integration, and data interpretation, and outline future directions to enhance scalability and clinical adoption in personalized medicine and decentralized health care.
No takes yet. Share an insight, caveat, or question.
Ramirez-Priego et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: